SEC Form 4 · accession 0001127602-17-008150
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 22, 2017
Accepted (ET)
Feb 24, 2017 · 2:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 22, 2017 | M | 21,779 | $40.40 | A | 388,294 | D | |
| Common Stock | Feb 22, 2017 | S | 600 | $87.46 | D | 387,694 | D | |
| Common Stock | Feb 22, 2017 | S | 100 | $87.48 | D | 387,594 | D | |
| Common Stock | Feb 22, 2017 | S | 900 | $87.49 | D | 386,694 | D | |
| Common Stock | Feb 22, 2017 | S | 400 | $87.50 | D | 386,294 | D | |
| Common Stock | Feb 22, 2017 | S | 5 | $87.53 | D | 386,289 | D | |
| Common Stock | Feb 22, 2017 | S | 100 | $87.62 | D | 386,189 | D | |
| Common Stock | Feb 22, 2017 | S | 200 | $87.625 | D | 385,989 | D | |
| Common Stock | Feb 22, 2017 | S | 300 | $87.63 | D | 385,689 | D | |
| Common Stock | Feb 22, 2017 | S | 100 | $87.635 | D | 385,589 | D | |
| Common Stock | Feb 22, 2017 | S | 610 | $87.64 | D | 384,979 | D | |
| Common Stock | Feb 22, 2017 | S | 500 | $87.65 | D | 384,479 | D | |
| Common Stock | Feb 22, 2017 | S | 199 | $87.655 | D | 384,280 | D | |
| Common Stock | Feb 22, 2017 | S | 601 | $87.66 | D | 383,679 | D | |
| Common Stock | Feb 22, 2017 | S | 190 | $87.665 | D | 383,489 | D | |
| Common Stock | Feb 22, 2017 | S | 1,000 | $87.67 | D | 382,489 | D | |
| Common Stock | Feb 22, 2017 | S | 100 | $87.675 | D | 382,389 | D | |
| Common Stock | Feb 22, 2017 | S | 500 | $87.68 | D | 381,889 | D | |
| Common Stock | Feb 22, 2017 | S | 1,120 | $87.69 | D | 380,769 | D | |
| Common Stock | Feb 22, 2017 | S | 7 | $87.695 | D | 380,762 | D | |
| Common Stock | Feb 22, 2017 | S | 200 | $87.70 | D | 380,562 | D | |
| Common Stock | Feb 22, 2017 | S | 293 | $87.71 | D | 380,269 | D | |
| Common Stock | Feb 22, 2017 | S | 192 | $87.72 | D | 380,077 | D | |
| Common Stock | Feb 22, 2017 | S | 200 | $87.725 | D | 379,877 | D | |
| Common Stock | Feb 22, 2017 | S | 1,200 | $87.73 | D | 378,677 | D | |
| Common Stock | Feb 22, 2017 | S | 100 | $87.745 | D | 378,577 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $40.40 | Feb 22, 2017 | M | 21,779 | D | Feb 22, 2014 | Feb 22, 2020 | Common Stock | 21,779 | 0 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.